Bruker BeatBox Instrument for tissue homogenization

Background
The National Institutes of Health (NIH), specifically the Eunice Kennedy Shriver National Institute on Child Health and Human Development (NICHD), is seeking to award a purchase order for the Bruker BeatBox Instrument for tissue homogenization. This acquisition is intended to enhance their research capabilities by providing a high-performance instrument that meets specific operational requirements. The NIH aims to procure this equipment without full and open competition due to Bruker Scientific, LLC being the original equipment manufacturer, ensuring that the instrument meets all necessary specifications.

Work Details
The contract involves the procurement of a Bruker BeatBox Instrument for tissue homogenization, which includes:
- Extended warranty
- Installation
- Delivery
- Bead remover
- Bead remover foil (10 pcs)
- Tissue Kit 24x.

The instrument must provide high throughput and speed, minimize sample loss and cross-contamination, generate minimal heat to preserve sample integrity, be compatible with formalin-fixed paraffin-embedded (FFPE) tissue samples, integrate seamlessly with downstream digestion and cleanup workflows, and have a demonstrated record of reliable performance. The BeatBox® Tissue Homogenizer is noted as the only instrument currently available that meets these specific requirements.

Period of Performance
08/11/2025 to 08/10/2026

Place of Performance
Delivery will take place at 5625 Fishers Lane, Rockville, MD 20852.